CONDENSED CONSOLIDATED INTERIM STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Apr. 30, 2025 |
Apr. 30, 2024 |
Apr. 30, 2025 |
Apr. 30, 2024 |
|
| CONDENSED CONSOLIDATED INTERIM STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) [Abstract] | ||||
| Revenues | $ 10,164 | $ 0 | $ 10,164 | $ 0 |
| Cost of sales | (2,688) | 0 | (2,688) | 0 |
| Gross profit | 7,476 | 0 | 7,476 | 0 |
| Operating expenses | ||||
| Sales and marketing | 155,496 | 38,756 | 832,188 | 365,406 |
| Depreciation | 231 | 450 | 953 | 1,374 |
| General and administrative | 235,972 | 103,229 | 627,377 | 393,231 |
| Professional fees | 841,536 | 942,688 | 6,846,934 | 4,263,900 |
| Salaries and wages | 353,808 | 464,003 | 1,013,152 | 1,666,150 |
| Total operating expenses | (1,587,043) | (1,549,126) | (9,320,604) | (6,690,061) |
| Other income (loss) | ||||
| Interest expense | (75,264) | (12,605) | (151,865) | (12,604) |
| Accretion expense | (57,908) | (20,528) | (226,853) | (23,072) |
| Change in fair value of derivative liabilities | 0 | (49,500) | 719,000 | (50,700) |
| Change in fair value of warrant liabilities | 5,641,785 | 0 | 5,651,008 | 0 |
| Change in fair value of mandatory convertible debentures | 0 | 0 | 70,500 | 0 |
| Impairment of carbon credits | 18 | 0 | (1,207,782) | 0 |
| Stop-loss provision loss | (76,535) | 0 | (1,101,248) | 0 |
| Equity loss on investment in associate | (298,804) | 0 | (405,654) | 0 |
| Gain on settlement of debt | 0 | 0 | 899,015 | 0 |
| Foreign exchange gain | (31,100) | (85,860) | (24,428) | (51,756) |
| Total other income (loss) | 5,102,192 | (168,493) | 4,221,693 | (138,132) |
| Net income (loss) | 3,522,625 | (1,717,619) | (5,091,435) | (6,828,193) |
| Other comprehensive gain (loss) | ||||
| Foreign currency translation | (373) | 107,513 | 1,435 | 66,577 |
| Net income (loss) and comprehensive income (loss) | $ 3,522,252 | $ (1,610,106) | $ (5,090,000) | $ (6,761,616) |
| Weighted average number of common shares outstanding - Basic (in shares) | 29,146,273 | 11,638,712 | 22,524,192 | 11,626,861 |
| Weighted average number of common shares outstanding - Diluted (in shares) | 30,629,440 | 11,638,712 | 22,524,192 | 11,626,861 |
| Income (Loss) per share - Basic (in dollars per share) | $ 0.12 | $ (0.15) | $ (0.23) | $ (0.59) |
| Income (Loss) per share - Diluted (in dollars per share) | $ 0.12 | $ (0.15) | $ (0.23) | $ (0.59) |
| X | ||||||||||
- Definition Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values considered as non operating. Excludes accretion associated with asset retirement obligations. No definition available.
|
| X | ||||||||||
- Definition Amount of impairment of carbon credits recognized during the period. No definition available.
|
| X | ||||||||||
- Definition Amount of stop-loss provision loss recognized during the period. No definition available.
|
| X | ||||||||||
- Definition The amount of unrealized gain (loss) on mandatory convertible debentures into convertible debt which may be settled in non cash upon conversion. No definition available.
|
| X | ||||||||||
- Definition Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of realized and unrealized gain (loss) on investment. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of interest expense classified as nonoperating. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for salary and wage arising from service rendered by nonofficer and officer employees. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold. No definition available.
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|